|Titre :||Increases in the availability of prescribed opioids in a Canadian setting (2012)|
|Auteurs :||B. NOSYK ; B. D. L. MARSHALL ; B. FISCHER ; J. S. G. MONTANER ; E. WOOD ; T. KERR|
|Type de document :||Article : Périodique|
|Dans :||Drug and Alcohol Dependence (Vol.126, n°1-2, November 2012)|
|Article en page(s) :||7-12|
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus TOXIBASEDIFFUSION DES PRODUITS ; MEDICAMENTS ; MESUSAGE ; PRODUIT ILLICITE ; PSYCHOTROPES ; METHADONE ; ETUDE PROSPECTIVE ; OPIOIDES
Background: The nonmedical use of prescribed opioids (POs) has increased across North America over the past decade. Our objective was to identify changes in the availability of POs and other illicit drugs among drug users in a Canadian setting.
Methods: Information on the availability of illicit drugs was collected in standardized interviews from a large observational research program involving illicit drug users in Vancouver, British Columbia from 2006 to 2010. The primary outcome was the perceived availability of a set of six POs (aspirin/oxycodone, hydromorphone, oxycodone, morphine, acetaminophen/codeine and methadone) among individuals reporting ever using POs. Availability was measured in three levels: not available, delayed availability (available >=10 min), and immediate availability (available Results: 1871 individuals were followed during the study period (2006–2010), including 583 (31.2%) women. The availability of POs increased over time, regardless of changes in the characteristics of cohort entrants. These increases were observed while the availability of traditional drugs of abuse (e.g., heroin and cocaine) remained constant. The adjusted odds of delayed availability vs. unavailability were between 34% (hydromorphone) and 71% (acetaminophen/codeine) greater in each calendar year.
Discussion: The availability of POs among drug users in a Canadian setting increased markedly over a relatively short timeframe, despite persistent and high availability of heroin and cocaine. Further study is required to determine the context of use of POs, associated harms, as well as policy responses to increasing availability.
|Domaine :||Autres substances / Other substances ; Drogues illicites / Illicit drugs|
|Affiliation :||British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada|